IgE-mediated
1 drugsPredictive biomarker for patient selection in 6 indications
1
Approved Drugs
6
Indications
1
Companies
IgE-mediated is a precision-medicine biomarker linked to 1 FDA-approved targeted drug from 1 company, spanning 6 indications including Asthma, Chronic Rhinosinusitis, Nasal Polyps. Explore the targeted therapies, indications, testing methods, and companies developing IgE-mediated drugs below.
Search IgE-mediated Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting IgE-mediated
| Drug | Company | Therapeutic Area |
|---|---|---|
| XOLAIR | Roche | Respiratory |